The tools we use in research should reflect the full spectrum of genetic diversity, but they often do not. This is a gap that an international team of scientists is exploring through the lens of induced pluripotent stem cell (iPSC) lines. iPSCs are a type...
Receiving a heart transplant is a life-changing journey, and you may be wondering about your treatment options. This is why The Heart Hub is excited to introduce A Hearts Journey: A Patient & Caregiver Guide to Heart Transplant. This brand-new, interactive...
On March 5, 2025, The Hospital for Sick Children (SickKids) received a significant breakthrough in pediatric research with an $11.7 million award from Genome Canada. As part of the Canadian Precision Health Initiative, a total of $81 million in...
After eight transformative years at the Ted Rogers Centre for Heart Research (TRCHR), Dr. Soror Sharifpoor is embarking on an exciting new chapter in her career. As the Director of Strategy & Translation at the Translational Biology and Engineering Program (TBEP)...
With a mission to support novel approaches to managing and preventing heart failure, the Ted Rogers Centre for Heart Research uses its Innovation Fund to propel emerging research with great potential. The 2024-25 Innovation Fund Seed Grants are currently open and you...
The Ted Rogers Centre for Heart Research is delighted to welcome Iris Cohn as the new Innovator in Genomic Translation - also recently promoted to Director of the Pharmacogenetics (PGx) Program at The Hospital for Sick Children. A trained pharmacist, Iris established...
Join us Wednesday, October 15, 2025 for ECHO PITCH, a special event where five top cardiovascular health start-ups compete for funding from a $250,000 pool in front of a panel of judges and a live audience.
These five finalists have been selected from the Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program, where they received 12 months of hands-on entrepreneurship training and mentorship.
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
Join us to learn, network, and set your entrepreneurial spirit free! Space is limited, so register early to reserve your spot!
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a specialized entrepreneurship training and mentorship program led by veteran entrepreneurs and consultants across a variety of sectors. Ventures participating in this 12-month online training program receive entrepreneurship training, mentorship, partnership and funding opportunities; support towards creating and growing their high-impact, health-focused startup; and tools to accelerate the translation of their health innovations from the bench to the bedside. ECHO was launched in 2018 under the University of Toronto’s Translational Biology and Engineering Program (TBEP) at the Ted Rogers Centre for Heart Research. To date, ECHO has supported 178 participants and 69 ventures, awarding over $1.5 million to help transform cutting-edge cardiovascular research into real-world solutions.
Building on this success, ECHO rebranded this year to the Entrepreneurship for Commercialization of Health Opportunities (ECHO) program, with expansion beyond its initial focus on cardiovascular health to include all areas of health research and care. ECHO is now led by the Temerty Faculty of Medicine, University of Toronto, in collaboration with TBEP, and with support from the Health Innovation Hub (H2i), Temerty Medicine’s health accelerator. To learn more, please visit https://rhse.temertymedicine.utoronto.ca/ECHO.